Docetaxel

国: ニュージーランド

言語: 英語

ソース: Medsafe (Medicines Safety Authority)

有効成分:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

から入手可能:

REX Medical Ltd

INN（国際名）:

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

投薬量:

80 mg/mL

医薬品形態:

Concentrate for infusion

構図:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

パッケージ内のユニット:

Vial, glass, Diluent, 6 mL

クラス:

Prescription

処方タイプ:

Prescription

製:

Cipla Ltd

適応症:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

製品概要:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

承認日:

2006-06-23